Title |
Action plans for COPD: strategies to manage exacerbations and improve outcomes
|
---|---|
Published in |
International Journal of Chronic Obstructive Pulmonary Disease, June 2016
|
DOI | 10.2147/copd.s76970 |
Pubmed ID | |
Authors |
Leena Jalota, Vipul V Jain |
Abstract |
COPD is the third-largest killer in the world, and certainly takes a toll on the health care system. Recurrent COPD exacerbations accelerate lung-function decline, worsen mortality, and consume over US$50 billion in health care spending annually. This has led to a tide of payment reforms eliciting interest in strategies reducing preventable COPD exacerbations. In this review, we analyze and discuss the evidence for COPD action plan-based self-management strategies. Although action plans may provide stabilization of acute symptomatology, there are several limitations. These include patient-centered attributes, such as comprehension and adherence, and nonadherence of health care providers to established guidelines. While no single intervention can be expected independently to translate into improved outcomes, structured together within a comprehensive integrated disease-management program, they may provide a robust paradigm. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 75% |
Unknown | 1 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 75% |
Practitioners (doctors, other healthcare professionals) | 1 | 25% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | <1% |
Unknown | 107 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 19 | 18% |
Student > Ph. D. Student | 15 | 14% |
Student > Doctoral Student | 11 | 10% |
Student > Bachelor | 9 | 8% |
Researcher | 7 | 6% |
Other | 13 | 12% |
Unknown | 34 | 31% |
Readers by discipline | Count | As % |
---|---|---|
Nursing and Health Professions | 21 | 19% |
Medicine and Dentistry | 18 | 17% |
Psychology | 10 | 9% |
Social Sciences | 9 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 5% |
Other | 10 | 9% |
Unknown | 35 | 32% |